NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 48 / 982

  1. Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study2026 · OpenAlex
  2. Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study2026 · OpenAlex
  3. Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans.2026 · PubMed
  4. Mystical Experiences Mediate the Effects of Psilocybin-Assisted Psychotherapy + Mindfulness-Based Stress Reduction on Trait Mindfulness and Depression Symptoms: Mechanistic Results from a Randomized Controlled Trial2026 · OpenAlex
  5. MÉTODOS DE EXTRACAO DE CANNABIS SATIVA:2026 · Crossref
  6. Métodos experimentales en psicoanálisis: Reflexiones epistemológicas sobre sustancias psicoactivas y el inconsciente2026 · OpenAlex
  7. N , N -Diisopropyltryptamine and diptogenia: proposed mechanisms for a frequency-selective pitch-distorting psychedelic2026 · Crossref
  8. N,N-Dimethyltryptamine (DMT) Acutely Exposed to Mouse Ventral Tegmental Area I<sub>h</sub>-Negative Neurons Alters the Firing Rate and Conductance in a Sex-Dependent Manner.2026 · PubMed
  9. N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state.2026 · PubMed
  10. N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine.2026 · PubMed
  11. N-pyrrolidino isotonitazene and its metabolites in post-mortem casework.2026 · PubMed
  12. NADPH oxidase-1 suppression prolongs the antidepressant-like effect of ketamine.2026 · PubMed
  13. Naloxone Access in Schools: A National Survey of School Nurses in the United States2026 · Crossref
  14. Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study.2026 · PubMed
  15. Naloxone and Buprenorphine Treatment for Adolescent Opioid Overdose and Opioid Use Disorder2026 · Crossref
  16. Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy2026 · Crossref
  17. Naloxone plus enteral nutrition for gastrointestinal dysfunction in elderly cerebral infarction and peptic ulcer patients2026 · Crossref
  18. Naloxone Training Among Sorority-Affiliated College Students: An Observational Study2026 · Crossref
  19. Nanocarrier-Based Drug Delivery Approaches for the Treatment of Depression, Anxiety, and Stress Related to Technology Addiction among Students2026 · Crossref
  20. Nanomedicine in the Use of Opioids: Enhancing Analgesia, Mitigating Harm2026 · Crossref
  21. Narcos of the Caribbean: Addressing Transshipment Drug Trafficking Through Caribbean Ports2026 · Crossref
  22. Narcotics and Drug Abuse in India: Legal Control, Positive Measures and Failures2026 · Crossref
  23. Narcotrafficking Across a Nation: The Juxtaposition of NGOs Work and Illicit Activities Embedding into the Licit Economy in Rural Honduras2026 · Crossref
  24. Naringenin Alleviates Acute Ethanol Exposure-induced Nerve Injury Through Regulating Neuroinflammation via PI3K/AKT Pathway-Mediated Modulation of Microglial M1/M2 Polarization2026 · OpenAlex
  25. Naringin preserved cognitive function through modulation of cholinergic dysfunction, oxidative stress, and synaptic proteins in scopolamine-induced cognitive impairment.2026 · PubMed
  26. Narrating Suffering Through the Lens of Trauma: A Narcofeminist Analysis of Addiction Narratives2026 · Crossref
  27. Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study2026 · OpenAlex
  28. Narrative Review: Self-Compassion dalam Hubungan Attachment dengan Emotional Dependency Wanita Dewasa Awal2026 · Crossref
  29. Narratives of Addiction or Addiction to Narratives?: The Role of Culture-Specific Knowledge in the Recognition and Diagnosis of Addictive Disorders2026 · Crossref
  30. Nasal spray addiction: Further thoughts and observations –A qualitative analysis of addiction components in “rhinitis medicamentosa” by Lakatos et al. (2025)2026 · Crossref
  31. Nathan S. Kline: From the first treatments of psychosis and depression, a 70-year legacy of a pioneer of psychopharmacology2026 · Crossref
  32. National bill seeks to jump‐start psychedelic treatment for veterans2026 · Crossref
  33. National review of state laws on opioid antagonists in Kindergarten-12th grade schools across the United States.2026 · PubMed
  34. National Survey on Magnitude of Substance Use in India: Survey Methodology2026 · Crossref
  35. National trends in naloxone codispensing with outpatient opioid prescriptions, 2013-2023.2026 · PubMed
  36. National trends, disparities and forecasts in substance use disorder–related suicide mortality in the United States: a CDC WONDER analysis2026 · Crossref
  37. Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health2026 · Crossref
  38. Natural and synthetic cannabinoids. Mechanism of action, drug addiction and associated risk factors2026 · Crossref
  39. Natural Deep Eutectic Solvent Extraction Optimization of Alkaloids from Mitragyna speciosa: A Methodological Evaluation.2026 · PubMed
  40. Natural Deep Eutectic Solvents for Enhanced Polyphenol Extraction From Edible Medicinal Plants With an Emphasis on Citrus limon L.2026 · Crossref
  41. Natural Hydrophobic Deep Eutectic Solvent-Based Enhanced Extraction of Bioactive Compounds from Cannabis sativa L. Leaf for Pharmaceutical Applications2026 · Crossref
  42. Natural Language Processing for Substance Use Disorder Information Extraction: A Systematic Literature Review2026 · Crossref
  43. Natural Language Processing Identification of Nonprescribed Fentanyl Use in Electronic Health Records: Algorithm Development and Validation Study.2026 · PubMed
  44. Natural Language Processing to Identify Substance Use in Electronic Health Records: A Scoping Review2026 · Crossref
  45. Natural medicine‑empowered treatment of depression via restoring neurogenesis (Review).2026 · PubMed
  46. Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities.2026 · PubMed
  47. Natural Tobacco Flavor Profiling Under Heat-Not-Burn Conditions Using Reference Tobacco Leaves and Tobacco from 1R6F Reference Cigarettes2026 · Crossref
  48. Naturaleza, cultura y prohibición: de los orígenes rituales del consumo de drogas a la regulación jurídica contemporánea2026 · Crossref
  49. Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development.2026 · PubMed
  50. Navigating an unpredictable supply: lived experiences of xylazine exposure among people who use drugs.2026 · PubMed
  51. Navigating between spaces: faith-based stigma among South Asian and Muslim carers of individuals with problematic drug and alcohol use2026 · Crossref
  52. Navigating chronic pain: aqualitative inquiry of experiences, impacts and treatments among medical cannabis patients in Pennsylvania2026 · Crossref
  53. Navigating Consent and Confidentiality in Adolescent Substance Use Treatment.2026 · PubMed
  54. Navigating Identification and Management of Substance Use in Adolescents.2026 · PubMed
  55. Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA2026 · Crossref
  56. Navigating the Conversation: How Can the News Media Responsibly Communicate Drug Use to the Australian Community?2026 · PubMed
  57. Navigating the Therapeutic Potential of Ego Dissolution2026 · OpenAlex
  58. Navigating ‘k-land’: a qualitative exploration of participants’ experiences of ketamine-assisted psychotherapy for methamphetamine use disorder2026 · Crossref
  59. Near-Infrared Spectroscopy-Based Discriminant Analysis for the Classification of Coffee Quality in Dry Parchment and Green Coffee2026 · Crossref
  60. Need for specialty addiction clinic services: Findings from a newly established addiction medicine clinic2026 · Crossref
  61. Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013-2023.2026 · PubMed
  62. Negative expectancies of drinking may be powerful in teens2026 · Crossref
  63. Neighborhood Environmental Interventions and Opioid Overdose Rates.2026 · PubMed
  64. Neonatal Infectious Harm Reduction Benefits of Maternal Substance Use Treatment: A Dyad-Based Retrospective Review2026 · Crossref
  65. Network dysregulation in depression: A synthesis of HPA Axis, BDNF signaling, and neurotransmitter interactions across multidimensional systems.2026 · PubMed
  66. Network intervention analysis of ACT processes in cocaine use disorder.2026 · PubMed
  67. Network modeling predicts how DYRK1A inhibition promotes cardiomyocyte cycling after ischemic/reperfusion injury.2026 · PubMed
  68. Network Pharmacology and Molecular Docking-Based Evaluation of Bacopa monnieri for Neuroprotection in Alzheimer’s Disease2026 · OpenAlex
  69. Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.2026 · PubMed
  70. Network pharmacology, molecular docking and <i>In vivo</i> validation reveal the neuroprotective effects of TT-TeMac™ against cholinergic dysfunction and hippocampal lesions.2026 · PubMed
  71. Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic Evidence2026 · OpenAlex
  72. Neural Correlates of Emotion Regulation in Substance Use2026 · Crossref
  73. Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans.2026 · PubMed
  74. Neural Network‐Based Detection of Adulterants in Opioid Samples Using IR Absorption Spectroscopy2026 · Crossref
  75. Neural Repair Therapies After Stroke: I. Therapeutic Advances.2026 · PubMed
  76. Neural signaling mechanisms in depression: bridging classical monoamine hypotheses, animal models, and emerging antidepressant strategies2026 · OpenAlex
  77. Neural Tube Defects (NTDs) and Modifiable Maternal Behavioral Risks in a Low-Resource Setting: Evidence From a Multicenter, Hospital-Based, Case-Control Study in Ethiopia.2026 · PubMed
  78. Neurobiological subtypes in alcohol use disorder and their phenotypic and clinical profiles2026 · Crossref
  79. Neurobiology of negative reinforcement as a driving force in alcohol addiction.2026 · PubMed
  80. Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case report.2026 · PubMed
  81. Neurodevelopmental and Psychiatric Disorders and the Use of Psychotropic Medications in a National Sample of Individuals With Juvenile Neuronal Ceroid Lipofuscinosis.2026 · PubMed
  82. Neurogenetic Profiles of Anxiety, Impulsivity, and Personality Traits in Elite Combat Sport Athletes: A Cluster-Based Analysis2026 · Crossref
  83. Neuroimaging and consciousness: applications of PET, SPECT, and advanced MRI modalities2026 · OpenAlex
  84. Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map2026 · Crossref
  85. Neuroinflammation, the gut-brain axis, and psychedelic-assisted psychotherapy: A synthesis of emerging paradigms in psychiatric care2026 · OpenAlex
  86. Neuroinflammatory-related biomarkers and psychiatric symptom changes in substance use disorder: a South African cohort study2026 · Crossref
  87. Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential.2026 · PubMed
  88. Neuropharmacology of levamisole and its phase I metabolites: lack of evidence for levamisole-cocaine interactions.2026 · PubMed
  89. Neurophysiological Characteristics of Nitrous Oxide-Induced Polyneuropathy: A Case Series.2026 · PubMed
  90. Neurophysiological Effects of Traditionally-Prepared Kava Measured by EEG: A Pilot Case Study2026 · OpenAlex
  91. Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.2026 · PubMed
  92. Neuroplasticity and recovery of the brain affected by substance use disorder: multilevel mechanisms and new therapeutic strategies (2020–2025)2026 · Crossref
  93. Neuroprotective Medicinal Plants in Ayurveda: A Compilation Review2026 · Crossref
  94. Neuropsychological Effects of Cannabis Use in Adolescent Populations: A Case Based Literature Review2026 · Crossref
  95. Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders2026 · Crossref
  96. Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT<sub>2A</sub> receptor agonists.2026 · PubMed
  97. Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration.2026 · PubMed
  98. Neurotoxicity and inflammation induction in the early life stage of zebrafish in response to harmane exposure.2026 · PubMed
  99. Neurotransmitter dysregulation in depression, anxiety, and suicidality: From synaptic dysfunction to cellular pathogenesis.2026 · PubMed
  100. Neurotransmitters in memory destabilization: An integrative perspective framed by prediction error and novelty.2026 · PubMed